Formulation and Evaluation of Trilayered Tablets of Zolmitriptan

DOI:

https://doi.org/10.37285/ijpsn.2016.9.6.1

Authors

  • Abdul Saleem Mohammad
  • Seema Farheen
  • Nuha Rasheed

Abstract

The present study outlines a systematic approach to formulate and evaluate trilayered tablets of zolmitriptan by geomatrix technology by using different concentrations of HPMC, xanthangum and ethyl cellulose by direct compression method for controlled release, which may produce the controlled drug release in the treatment of migraine disorder. The different release rates from these formulations were obtained from in vitro dissolution studies. From the results it was observed that the release rate was greatly influenced by the polymer concentration. In order to obtain a formulation which releases more than 90% of drug within 12-14hrs, sixteen formulation trials of the active layer have been prepared and the drug release follows first order kinetics. Hence, the formulation trial F14  showed about 99% drug release in 12 hrs, where the drug release was dependent on concentration of drug in tablets  and showed various physiochemical evaluation parameters like hardness, thickness and also showed  drug excipient compatibilities by DSC and FTIR studies. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Zolmitriptan, Geomatrix technology, Direct compression, DSC, FTIR

Downloads

Published

2016-11-30

How to Cite

1.
Mohammad AS, Farheen S, Rasheed N. Formulation and Evaluation of Trilayered Tablets of Zolmitriptan . Scopus Indexed [Internet]. 2016 Nov. 30 [cited 2024 Sep. 16];9(6):3512-23. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/888

Issue

Section

Research Articles

References

Chien YW (2009). Novel Drug Delivery System. By Informa Healthcare. Second Edition; pp.139-140.

Choi YW, Cui JH, Lee BJ (2005). Formulation, release characteristics and bioavailability of novel monolithic hydroxyl propylmethyl-cellulose matrix tablet containing acetaminophen. Journal of Control Release; 108: 351-361.

Namdeo B (2008). Barrier layers in multilayered tablets. Express Pharma.

Kulkarni A, Bhatia M (2009). Development and evaluation of bilayer floating tablets of atenolol and lovastatin for biphasic release profile. Iran. J Pharm Res; 8: 15-25.

Gautam CS, Saha L (2008). Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J ClinPharmacol; 65: 795-796.

Qiu YN. Chidambaram K (1998). Design and evaluation of layered diffusional matrices for zeroorder sustained-release. Journal of Control. Release; 51: 123-130.

Vyas SP, Khar RK (2002). Controlled drug delivery. Concept and advances, 1st edition, Vallabhaprakashan, Delhi, pp.: 267-347.

Lachman Leon, Lieberman Herbert A (2002). Compression coated and layer tablets. In: Pharmaceutical Dosage Forms: Tablets. 2nd Edition, Marcel Dekker, Inc. New York, Vol1, pp. 247-84.

T. Praveen Kumar, Y. Pallavi, K. Deepthi, P. NarayanaRaju (2014). Formulation and evaluation of Entacapone sustained, release matrix tablets, The Pharma Innovation Journal 3(8): 80-88

VenkateswaraRao T, Bhadramma N, Raghukiran CVS, Madubabu K (2013). Design and development of Metformin hydrochloride Trilayered sustained release tablets, Indian Journal of Research in Pharmacy and Biotechnology 1(6): 893-897.

Prathima Srinivas M, Chaitanya. N (2013). Formulation and evaluation of sitagliptin phosphate and Metformin hydrochloride trilayered tablets, International Journal of Drug Delivery 5: 15-27.

Most read articles by the same author(s)